HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bharti, A. C. Articles by Aggarwal, B. B. Search for Related Content PubMed PubMed Citation Articles by Bharti, A. C. Articles by Aggarwal, B. B.

Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF-B Ligand-Induced NF-B Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis¹

Cytokine Research Section, Department of Bioimmunotherapy, Unit 143, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030

Numerous studies have indicated that inflammatory cytokines play a major role in osteoclastogenesis, leading to the bone resorption that is frequently associated with cancers and other diseases. Gene deletion studies have shown that receptor activator of NF-B ligand (RANKL) is one of the critical mediators of osteoclastogenesis. How RANKL mediates osteoclastogenesis is not fully understood, but an agent that suppresses RANKL signaling has potential to inhibit osteoclastogenesis. In this report, we examine the ability of curcumin (diferuloylmethane), a pigment derived from turmeric, to suppress RANKL signaling and osteoclastogenesis in RAW 264.7 cells, a murine monocytic cell line. Treatment of these cells with RANKL activated NF-B, and preexposure of the cells to curcumin completely suppressed RANKL-induced NF-B activation. Curcumin inhibited the pathway leading from activation of IB kinase and IB phosphorylation to IB degradation. RANKL induced osteoclastogenesis in these monocytic cells, and curcumin inhibited both RANKL- and TNF-induced osteoclastogenesis and pit formation. Curcumin suppressed osteoclastogenesis maximally when added together with RANKL and minimally when it was added 2 days after RANKL. Whether curcumin inhibits RANKL-induced osteoclastogenesis through suppression of NF-B was also confirmed independently, as RANKL failed to activate NF-B in cells stably transfected with a dominant-negative form of IB and concurrently failed to induce osteoclastogenesis. Thus overall these results indicate that RANKL induces osteoclastogenesis through the activation of NF-B, and treatment with curcumin inhibits both the NF-B activation and osteoclastogenesis induced by RANKL.

This article has been cited by other articles:

				S. P. Weisberg, R. Leibel, and D. V. Tortoriello Dietary Curcumin Significantly Improves Obesity-Associated Inflammation and Diabetes in Mouse Models of Diabesity Endocrinology, July 1, 2008; 149(7): 3549 - 3558. [Abstract] [Full Text] [PDF]

				A. B. Kunnumakkara, A. S. Nair, K. S. Ahn, M. K. Pandey, Z. Yi, M. Liu, and B. B. Aggarwal Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-{kappa}B activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis Blood, June 15, 2007; 109(12): 5112 - 5121. [Abstract] [Full Text] [PDF]

				X. Si, Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication J. Virol., April 1, 2007; 81(7): 3142 - 3150. [Abstract] [Full Text] [PDF]

				K. S. Ahn, G. Sethi, S. Shishodia, B. Sung, J. L. Arbiser, and B. B. Aggarwal Honokiol Potentiates Apoptosis, Suppresses Osteoclastogenesis, and Inhibits Invasion through Modulation of Nuclear Factor-{kappa}B Activation Pathway Mol. Cancer Res., September 1, 2006; 4(9): 621 - 633. [Abstract] [Full Text] [PDF]

				M. F. McCarty and K. I. Block Toward a core nutraceutical program for cancer management. Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171. [Abstract] [PDF]

				H. Ichikawa and B. B. Aggarwal Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-{kappa}B Ligand and by Tumor Cells by Suppressing Nuclear Factor-{kappa}B Activation Clin. Cancer Res., January 15, 2006; 12(2): 662 - 668. [Abstract] [Full Text] [PDF]

				W. Cui, J. Z. Ke, Q. Zhang, H.-Z. Ke, C. Chalouni, and A. Vignery The intracellular domain of CD44 promotes the fusion of macrophages Blood, January 15, 2006; 107(2): 796 - 805. [Abstract] [Full Text] [PDF]

				F. Y.-I. Lee, D.-W. Kim, J. A. Karmin, D. Hong, S.-S. Chang, M. Fujisawa, H. Takayanagi, L. U. Bigliani, T. A. Blaine, and H.-J. Lee {micro}-Calpain Regulates Receptor Activator of NF-{kappa}B Ligand (RANKL)-supported Osteoclastogenesis via NF-{kappa}B Activation in RAW 264.7 Cells J. Biol. Chem., August 19, 2005; 280(33): 29929 - 29936. [Abstract] [Full Text] [PDF]